Prospective Study of Sinonasal and Skull-base Tumours Management
Sinonasal_Tu
Prospective Observational Study of Sinonasal and Skull-base Tumours Management in a Tertiary Referral Otorhinolaryngology Service
1 other identifier
observational
120
1 country
1
Brief Summary
This observational prospective clinical study aims to describe the epidemiology, management and outcome of patients with sinonasal and skull-base pathology (tumours and diseases with malignant clinical characteristics) in a tertiary otorhinolaryngology referral centre. The main questions it aims to answer are:
- what is the caseload of patients with the included pathology in our centre
- what are the results of management of these cases
- what are the epidemiological characteristics of included patients
- what is the quality of life of included patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
October 30, 2022
CompletedFirst Posted
Study publicly available on registry
November 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
April 29, 2026
April 1, 2026
5 years
October 30, 2022
April 27, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Absence of the disease
Absence of the disease after the treatment has been completed
twelve months after the treatment completion
Overall survival
Survival after the treatment has been completed
twelve months after the treatment completion
Eligibility Criteria
The study population will be recruited from patients referred to the tertiary otorhinolaryngology referral centre. The referral applies to the in-hospital or outpatient setting.
You may qualify if:
- sinonasal and/or skull-base cancer
- sinonasal disease expanding through the skull-base
- the patient's written informed consent
You may not qualify if:
- lateral skull-base disease primarily originating in the temporal bone and without central skull-base involvement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Centre Ljubljana
Ljubljana, Ljubljana, 1000, Slovenia
Related Publications (1)
Vozel D, Urbancic J, Battelino S, Urbancic NB, Steiner N, Felbabic T, Bosnjak R. Quality of life in Slovenian patients with skull base tumours: cross-cultural adaptation and validation of a Slovenian skull base inventory. Radiol Oncol. 2026 Jan 21;60(1):106-113. doi: 10.2478/raon-2026-0007. eCollection 2026 Mar 1.
PMID: 41560283DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Domen Vozel, MD, PhD
University Medical Centre Ljubljana
- STUDY DIRECTOR
Jure Urbančič, MD
University Medical Centre Ljubljana
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Domen Vozel, MD, PhD, principal investigator
Study Record Dates
First Submitted
October 30, 2022
First Posted
November 7, 2022
Study Start
January 1, 2022
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
April 29, 2026
Record last verified: 2026-04